Product Images Epoprostenol
View Photos of Packaging, Labels & Appearance
- epoprostenol-spl-carton-label-0-5mg - epoprostenol spl carton label 0 5mg
- epoprostenol-spl-carton-label-1-5mg - epoprostenol spl carton label 1 5mg
- epoprostenol-spl-container-label-0-5mg - epoprostenol spl container label 0 5mg
- epoprostenol-spl-container-label-1-5mg - epoprostenol spl container label 1 5mg
- epoprostenol-spl-structure - epoprostenol spl structure
Product Label Images
The following 5 images provide visual information about the product associated with Epoprostenol NDC 68083-642 by Gland Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
epoprostenol-spl-carton-label-0-5mg - epoprostenol spl carton label 0 5mg
Description: This is a product information sheet for Epoprostenol for Injection manufactured by Gland Pharma Limited in Hyderabad, India. The product comes in single-dose vials and is intended for intravenous infusion only. Each vial contains epoprostenol sodium, sucrose, glycine, and sodium hydroxide to adjust pH. The dosage and storage instructions, as well as details on prescribing information and stability, are provided. The product is stored at 20°C to 25°C with excursions permitted to 15° to 30°C and should be protected from light. Dilution instructions and room temperature storage stability information are also included.*
epoprostenol-spl-carton-label-1-5mg - epoprostenol spl carton label 1 5mg
This is a label for Epoprostenol for injection, a medication used for intravenous infusion. Each vial contains epoprostenol sodium, sucrose, glycine, and sodium hydroxide. The dosage and storage instructions are provided on the label. It is manufactured by Gland Pharma Limited in India.*
epoprostenol-spl-container-label-0-5mg - epoprostenol spl container label 0 5mg
This text seems to be a pharmaceutical label for a medication that needs to be reconstituted before use. The manufacturer is Gland Pharma Limited from Hyderabad, India. The product is intended for intravenous infusion only and should be stored at controlled room temperature. The medication is in a sterile, lyophilized form in a single-dose vial. After reconstitution, the correct dose should be withdrawn and diluted to the final concentration in a reservoir. Unused portions should be discarded.*
epoprostenol-spl-container-label-1-5mg - epoprostenol spl container label 1 5mg
This is a description of Epoprostenol for Injection, a sterile, lyophilized product packaged in single-dose vials for intravenous infusion only. The instructions indicate to discard any unused portion after reconstitution, store the product at 20°C to 25°C, protect it from light, and dilute to the final concentration in a reservoir. The manufacturing information reveals that it is produced by Gland Pharma Limited in Hyderabad, India. The provided NDC code for this product is 68083-642-01.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.